Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT Study in below-knee deep vein thrombosis
2010-021813-22Phase 4Completed
- Sponsor
- Manchester University NHS Foundation Trust
- Start
- Oct 2010
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of warfarin and dalteparin in deep vein thrombosis (DVT) (2 arms), sponsored by Manchester University NHS Foundation Trust. Primary endpoint: Primary efficacy endpoint. Started Oct 2010; status: completed.
02
Drugs
warfarindalteparin
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on 2010-021813-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021813-22.